About the Authors
- Paolo Arosio
-
Affiliation Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
- Marta Owczarz
-
Affiliation Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
- Thomas Müller-Späth
-
Affiliation Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
- Paola Rognoni
-
Affiliation Amyloid Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
- Marten Beeg
-
Affiliation Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
- Hua Wu
-
Affiliation Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
- Mario Salmona
-
Affiliation Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche “Mario Negri,” Milan, Italy
- Massimo Morbidelli
-
* E-mail: massimo.morbidelli@chem.ethz.ch
Affiliation Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: PA TMS HW MS MM. Performed the experiments: PA MO MB PR. Analyzed the data: PA MS MM. Wrote the paper: PA MS MM.